iShares Biotechnology ETF (NASDAQ:IBB) to Issue Dividend Increase – $0.12 Per Share

iShares Biotechnology ETF (NASDAQ:IBB) declared a dividend on Monday, March 17th, NASDAQ Dividends reports. Investors of record on Tuesday, March 18th will be paid a dividend of 0.1212 per share by the financial services provider on Friday, March 21st. The ex-dividend date is Tuesday, March 18th. This is a 94.3% increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Price Performance

NASDAQ IBB traded down $2.01 during trading on Tuesday, hitting $134.09. The company’s stock had a trading volume of 509,360 shares, compared to its average volume of 1,325,954. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The company has a market cap of $6.11 billion, a PE ratio of 27.83 and a beta of 0.77. The business’s 50 day simple moving average is $136.28 and its 200-day simple moving average is $139.67.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Biotechnology ETF stock. Brighton Jones LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,517 shares of the financial services provider’s stock, valued at approximately $201,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.